Yearly Archives: 2019

sphingotec’s endothelial function biomarker bio-ADM® predicts need for organ support in general ICU patient population

Data from more than 2,000 patients enrolled in the FROG-ICU study demonstrate that high levels of bioactive adrenomedullin (bio-ADM®) predict the need for organ support, ionotropes, and vasopressors in the general patient population at admission to the intensive care unit (ICU). bio-ADM® screening of patients admitted for septic or non-septic reasons supports stratification of risk…
Read more

sphingotec’s biomarker penKid® predicts septic acute kidney injury at time of admission to emergency department

Sphingotec reports study data demonstrating that its proprietary renal function biomarker penKid® (Proenkephalin) predicts acute kidney injury (AKI), multi-organ failure and mortality in sepsis patients presenting to the emergency department (ED). High penKid® plasma levels identified all ED patients with hidden AKI and AKI at admission and reflected worsening of kidney function. penKid® point-of-care (POC) implementation…
Read more

sphingotec’s proprietary biomarker bio-ADM® detects residual congestion in patients with heart failure

Data from more than 1,200 patients of the PROTECT study demonstrate that high levels of the endothelial function biomarker bio-ADM® (bioactive Adrenomedullin) indicate residual congestion of heart failure patients. Endothelial dysfunction, indicated by high bio-ADM® levels, leads to fluid leakage from blood vessels and ultimately resulting in tissue congestion. With 25% of heart failure patients…
Read more

Sphingotec to Present Novel Acute Care Biomarkers and Point-of-Care Diagnostic Solutions at Medica 2019

Hennigsdorf, Germany, November 15, 2019 - SphingoTec GmbH (“sphingotec”) today announced that latest advancements in the development of its portfolio of novel biomarkers and diagnostic solutions will be showcased at Medica 2019 in Düsseldorf, Germany. To improve the management of critically ill patients in acute care settings through timely diagnostic, sphingotec has started making available…
Read more